Periodic Reporting for period 1 - GLIOHAB (Multiparametric imaging of glioblastoma tumour heterogeneity for supporting treatment decisions and accurate prognostic estimation)

Glioblastoma is the most frequent primary brain tumor. Glioblastoma has a poor prognosis, with an average survival of 14.6 months for patients undergoing Stupp standard treatment. Due to the extremely complex and heterogeneous molecular biology of glioblastoma “the same...